The federal Food and Drug Administration (FDA) recently won a case against Eli Lilly & Co. when the company agreed to plead guilty and pay $36 million in connection with illegal promotion of its pharmaceutical drug Evista. What did the company do to earn such a penalty?

A February 3, 2006 piece by Rosalind Lacy MacLennan gives ACSH's book America's War on "Carcinogens" a positive review:

A story in the February 1, 2006 Chemical Week describes ACSH's effort to get EPA to explain the divergence between its regulations and its science on chemicals:

How much do we really know about the origin and spread of the 1918 flu pandemic? Comparisons with other pandemics reveal patterns and lingering mysteries.
Watching the Animals
"The horses growing better, a cough and sore throat seized mankind." This was the news from Dublin toward the end of 1727, reported in Charles Creighton's monumental History of Epidemics in Britain -- Volume II -- From the Extinction of the Plague to the Present Time, Creighton's "present time" being 1894.

This column first appeared in the New York Post.

A January 29, 2006 "Blog On!" column by Dawn Eden described avowedly skeptical and counter-skeptical blogs, noting ACSH's own HealthFactsAndFears.com:

Thanks in part to an open letter/petition co-authored by ACSH and the Competitive Enterprise Institute (CEI, a DC-based free-market think tank), the Environmental Protection Agency (EPA) has decided to consider data gleaned from strictly-controlled studies involving human volunteers instead of relying solely on animal testing. Excluded from this new regulation will be children and pregnant women, except for a very few observational studies that have already been completed.

The Environmental Protection Agency (EPA) and certain activist groups are patting each other on the back now that DuPont and some other companies have "voluntarily" signed onto an EPA program aimed at reducing environmental contamination by the chemical PFOA, used in the manufacture of Teflon and other consumer products.
These companies have agreed -- or soon will -- to reduce the level of PFOA in emissions and in their products by 95% within the next four years, and to zero (if possible) by 2015.

Unfortunately for their self-image, the French, like the citizens of virtually every other country, are fighting the battle of the bulge. They can no longer be considered immune to the rising tide of obesity that has been occurring in the U.S. of late, according to an article in the International New York Times.

Overweight and obese Americans may soon have easy access to orlistat (sold as Alli), a drug that has been shown to be helpful to those trying to lose weight and improve their health. An advisory committee to the Food and Drug Administration (FDA) has recommended approval of GlaxoSmithKline's application to sell orlistat over the counter (OTC), that is, without requiring a doctor's prescription. While the FDA doesn't have to follow advisory committees' recommendations, it usually does so.